Pages

▼
Sunday, December 23, 2018

Hydroxychloroquine (Plaquenil) Starts a Phase-II? Trial To Prevent Type-1 In Presymptomatics

›
This study is testing a medication, called hydroxychloroquine (HCQ) to assess safety and effectiveness to prevent individuals at risk of ty...
Saturday, December 1, 2018

Vitamin D and Omega-3s (EPA/DHA "Fish Oil") Start a Patient Driven Study

›
This study is interesting for two reasons.  First, because of what is it testing as a possible prevention of type-1 diabetes.  Second, becau...
2 comments:
Monday, October 29, 2018

Golimumab Update

›
Golimumab (sold as Simponi) is an immune system modulator, which has been approved in the United States and many other countries for treatme...
3 comments:
Sunday, October 7, 2018

JDRF Funding for a Cure 2018

›
In the US, we are in the "Walking Season" when JDRF asks us to walk to raise money for a cure. So I'd like to do my part, by r...
3 comments:
Saturday, September 29, 2018

Dropping Four Research Programs

›
Every year in September or October I write a blog posting which summarizes all research being done in humans, aimed at curing type-1 diabete...
3 comments:
Monday, September 17, 2018

NextCell Starts a Phase-I Study of Mesenchymal Stromal Cell Treatment

›
NextCell pharma is running a clinical trial of their ProTrans product.  This is a stem cell product derived from "Wharton´s Jelly"...
Sunday, September 2, 2018

Results from a Phase-II Verapamil Trial

›
Verapamil is a drug which has been used in the US since 1982 for high blood pressure, migraines, and heart problems.  It also lowers levels ...